EU Clinical Trial 2018-001661-17

Randomized Controlled Trial of Lasmiditan Over Four Migraine Attacks  Apr 23, 2019

Main objective of the trial: - To evaluate the efficacy of lasmiditan 200 mg and 100 mg on migraine headache pain freedom compared to placebo. - To evaluate the consistency of response to lasmiditan 200 mg and 100 mg compared to placebo.

Parties

Sponsors